Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Oct 07, 2021

SELL
$76.44 - $89.57 $696 Million - $816 Million
-9,108,713 Closed
0 $0
Q1 2021

Oct 07, 2021

SELL
$67.36 - $80.76 $278 Million - $334 Million
-4,129,829 Reduced 31.2%
9,108,713 $691 Million
Q4 2020

Feb 16, 2021

SELL
$53.08 - $69.86 $147 Million - $194 Million
-2,771,759 Reduced 17.31%
13,238,542 $902 Million
Q3 2020

Nov 13, 2020

SELL
$51.29 - $65.09 $166 Million - $210 Million
-3,233,719 Reduced 16.8%
16,010,301 $851 Million
Q2 2019

Jul 25, 2019

BUY
$40.81 - $52.42 $1.27 Million - $1.63 Million
31,017 Added 0.16%
19,244,020 $983 Million
Q4 2018

Jan 22, 2019

BUY
$36.49 - $51.72 $158,950 - $225,292
4,356 Added 0.02%
19,213,003 $756 Million
Q3 2018

Oct 30, 2018

SELL
$46.5 - $53.55 $277 Million - $319 Million
-5,966,191 Reduced 23.7%
19,208,647 $990 Million
Q1 2018

May 09, 2018

BUY
$31.7 - $44.1 $798 Million - $1.11 Billion
25,174,838 New
25,174,838 $894 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Thomas H Lee Partners LP Portfolio

Follow Thomas H Lee Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas H Lee Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Thomas H Lee Partners LP with notifications on news.